Wave Life Sciences Ltd’s filing revealed that its Director Verdine Gregory L. unloaded Company’s shares for reported $0.21 million on Jun 13 ’25. In the deal valued at $6.95 per share,30,000 shares were sold. As a result of this transaction, Verdine Gregory L. now holds 282,517 shares worth roughly $2.5 million.
Then, GREGORY VERDINE bought 30,000 shares, generating $216,000 in total proceeds.
Before that, HENRY CHRISTIAN O sold 10,500 shares. Wave Life Sciences Ltd shares valued at $102,574 were divested by the Director at a price of $9.77 per share. As a result of the transaction, HENRY CHRISTIAN O now holds 16,115 shares, worth roughly $0.14 million.
Canaccord Genuity initiated its Wave Life Sciences Ltd [WVE] rating to a Buy in a research note published on August 04, 2025; the price target was $19. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. Citigroup began covering WVE with “Buy” recommendation on July 16, 2025.
Price Performance Review of WVE
On Tuesday, Wave Life Sciences Ltd [NASDAQ:WVE] saw its stock jump 1.03% to $8.84. Over the last five days, the stock has gained 6.25%. Wave Life Sciences Ltd shares have risen nearly 43.51% since the year began. Nevertheless, the stocks have fallen -28.54% over the past one year.
How much short interest is there in Wave Life Sciences Ltd?
A steep rise in short interest was recorded in Wave Life Sciences Ltd stocks on 2025-07-15, growing by 1.52 million shares to a total of 16.41 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 14.88 million shares. There was a rise of 9.29%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 29, 2025 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $10 price target.
